MarketCap
Facebook
X
TelegramQuarterly report 2024-Q1
added 06-13-2026
DermTech DPO Ratio 2011-2026 | DMTK
Annual DPO Ratio DermTech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.4 | 69.7 | 76.9 | 97.1 | 105 | 19.9 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 105 | 19.9 | 69.3 |
Quarterly DPO Ratio DermTech
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.7 | 49.1 | 46 | 48.9 | - | 47.6 | 34 | 57.2 | - | 72.5 | 82.2 | 95.6 | - | 46.3 | 75 | 120 | - | 153 | 214 | 136 | - | 19 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 214 | 19 | 79.4 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 201.04 | -0.55 % | $ 22.3 B | USA |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
4.24 K | $ 3.84 | 1.59 % | $ 5.11 M | USA |
 |
Fulgent Genetics
FLGT
|
35.2 | $ 17.99 | -1.96 % | $ 554 M | USA |
 |
Castle Biosciences
CSTL
|
65.8 | $ 20.46 | -0.97 % | $ 593 M | USA |
 |
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
196 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
48.6 | $ 127.34 | -1.91 % | $ 16 B | USA |
 |
Interpace Biosciences
IDXG
|
33 | $ 1.57 | -0.32 % | $ 6.95 M | USA |
 |
CareDx, Inc
CDNA
|
44.2 | $ 23.25 | -3.45 % | $ 1.24 B | USA |
 |
Illumina
ILMN
|
57.1 | $ 164.28 | -1.56 % | $ 25.5 B | USA |
 |
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
11 | $ 143.54 | -2.83 % | $ 11.3 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
10.1 | $ 18.47 | 0.87 % | $ 413 M | USA |
 |
Lantheus Holdings
LNTH
|
23.6 | $ 105.03 | 0.34 % | $ 7.09 B | USA |
 |
Natera
NTRA
|
17.9 | $ 220.11 | 1.45 % | $ 30.1 B | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 184.79 | -2.04 % | $ 9.16 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
59.7 | - | - | $ 405 M | USA |
 |
Medpace Holdings
MEDP
|
13.3 | $ 461.6 | -1.26 % | $ 13.3 B | USA |
 |
Mettler-Toledo International
MTD
|
53.4 | $ 1 151.57 | -0.27 % | $ 23.7 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
19.7 | $ 10.49 | -5.41 % | $ 1.34 B | USA |
 |
Myriad Genetics
MYGN
|
45.9 | $ 4.25 | -1.62 % | $ 394 M | USA |
 |
Personalis
PSNL
|
65.7 | $ 9.69 | -1.02 % | $ 865 M | USA |
 |
Senseonics Holdings
SENS
|
68 | $ 7.23 | -0.14 % | $ 302 M | USA |
 |
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
1.44 K | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
12.5 | $ 84.95 | 5.15 % | $ 5.08 B | USA |
 |
Biomerica
BMRA
|
32.4 | $ 1.93 | -3.5 % | $ 4.43 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 264.76 | -0.1 % | $ 22 B | USA |
 |
Thermo Fisher Scientific
TMO
|
49.3 | $ 472.63 | -0.23 % | $ 178 B | USA |
 |
Trinity Biotech plc
TRIB
|
163 | $ 0.57 | -15.83 % | $ 205 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
62.7 | $ 9.31 | 0.11 % | $ 2.02 B | USA |
 |
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | USA |